Squarepoint Ops LLC Lineage Cell Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.89 - $1.47 $131,353 - $216,954	-147,588 Reduced 76.91%	44,307 $44,000
Q1 2024 May 15, 2024	BUY	$0.86 - $1.48 $15,993 - $27,523	18,597 Added 10.73%	191,895 $284,000
Q4 2023 Feb 14, 2024	BUY	$0.91 - $1.35 $128,649 - $190,853	141,373 Added 442.83%	173,298 $188,000
Q2 2023 Aug 14, 2023	SELL	$1.26 - $1.53 $1,173 - $1,424	-931 Reduced 2.83%	31,925 $45,000
Q1 2023 May 15, 2023	BUY	$1.2 - $1.53 $39,427 - $50,269	32,856 New	32,856 $49,000

120

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $91.7M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.